<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Regulatory Concerns Should Not Dominate Pharma Social Media</title>
	<atom:link href="http://prforpharma.com/2010/02/04/regulatory-concerns-should-not-dominate-pharma-social-media/feed/" rel="self" type="application/rss+xml" />
	<link>http://prforpharma.com/2010/02/04/regulatory-concerns-should-not-dominate-pharma-social-media/#utm_source=feed&#038;utm_medium=feed&#038;utm_campaign=feed</link>
	<description>Discussions about social media, PR and marketing for pharmaceutical companies</description>
	<lastBuildDate>Thu, 19 Jan 2012 21:23:35 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.1</generator>
	<item>
		<title>By: Gabor Gyarmati</title>
		<link>http://prforpharma.com/2010/02/04/regulatory-concerns-should-not-dominate-pharma-social-media/comment-page-1/#comment-912</link>
		<dc:creator>Gabor Gyarmati</dc:creator>
		<pubDate>Tue, 09 Feb 2010 00:05:46 +0000</pubDate>
		<guid isPermaLink="false">http://prforpharma.com/?p=134#comment-912</guid>
		<description>&lt;span class=&quot;topsy_trackback_comment&quot;&gt;&lt;span class=&quot;topsy_twitter_username&quot;&gt;&lt;span class=&quot;topsy_trackback_content&quot;&gt;Does pharma social media focus too much on AEs and off-label usage and not enough on the patient?: http://bit.ly/dpk6xC RT @PRforPharma&lt;/span&gt;&lt;/span&gt;</description>
		<content:encoded><![CDATA[<p><span class="topsy_trackback_comment"><span class="topsy_twitter_username"><span class="topsy_trackback_content">Does pharma social media focus too much on AEs and off-label usage and not enough on the patient?: <a href="http://bit.ly/dpk6xC" rel="nofollow">http://bit.ly/dpk6xC</a> RT @PRforPharma</span></span></span></p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Digital-Economics</title>
		<link>http://prforpharma.com/2010/02/04/regulatory-concerns-should-not-dominate-pharma-social-media/comment-page-1/#comment-913</link>
		<dc:creator>Digital-Economics</dc:creator>
		<pubDate>Sun, 07 Feb 2010 18:50:49 +0000</pubDate>
		<guid isPermaLink="false">http://prforpharma.com/?p=134#comment-913</guid>
		<description>&lt;span class=&quot;topsy_trackback_comment&quot;&gt;&lt;span class=&quot;topsy_twitter_username&quot;&gt;&lt;span class=&quot;topsy_trackback_content&quot;&gt;RT @ritters90 Great post from Chris Iafolla, Regulatory Concerns Should Not Dominate Pharma Social Media... http://bit.ly/cvTI1k #hcsm&lt;/span&gt;&lt;/span&gt;</description>
		<content:encoded><![CDATA[<p><span class="topsy_trackback_comment"><span class="topsy_twitter_username"><span class="topsy_trackback_content">RT @ritters90 Great post from Chris Iafolla, Regulatory Concerns Should Not Dominate Pharma Social Media&#8230; <a href="http://bit.ly/cvTI1k" rel="nofollow">http://bit.ly/cvTI1k</a> #hcsm</span></span></span></p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Ritesh Patel</title>
		<link>http://prforpharma.com/2010/02/04/regulatory-concerns-should-not-dominate-pharma-social-media/comment-page-1/#comment-914</link>
		<dc:creator>Ritesh Patel</dc:creator>
		<pubDate>Sun, 07 Feb 2010 18:49:43 +0000</pubDate>
		<guid isPermaLink="false">http://prforpharma.com/?p=134#comment-914</guid>
		<description>&lt;span class=&quot;topsy_trackback_comment&quot;&gt;&lt;span class=&quot;topsy_twitter_username&quot;&gt;&lt;span class=&quot;topsy_trackback_content&quot;&gt;Great post from Chris Iafolla, Regulatory Concerns Should Not Dominate Pharma Social Media... http://bit.ly/cvTI1k #hcsm&lt;/span&gt;&lt;/span&gt;</description>
		<content:encoded><![CDATA[<p><span class="topsy_trackback_comment"><span class="topsy_twitter_username"><span class="topsy_trackback_content">Great post from Chris Iafolla, Regulatory Concerns Should Not Dominate Pharma Social Media&#8230; <a href="http://bit.ly/cvTI1k" rel="nofollow">http://bit.ly/cvTI1k</a> #hcsm</span></span></span></p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Jerry Chapman</title>
		<link>http://prforpharma.com/2010/02/04/regulatory-concerns-should-not-dominate-pharma-social-media/comment-page-1/#comment-915</link>
		<dc:creator>Jerry Chapman</dc:creator>
		<pubDate>Sun, 07 Feb 2010 06:34:34 +0000</pubDate>
		<guid isPermaLink="false">http://prforpharma.com/?p=134#comment-915</guid>
		<description>&lt;span class=&quot;topsy_trackback_comment&quot;&gt;&lt;span class=&quot;topsy_twitter_username&quot;&gt;&lt;span class=&quot;topsy_trackback_content&quot;&gt;RT @DaphneLeigh: RT @PhilBaumann: Regulatory concerns shouldn&#039;t dominate pharma online. http://bit.ly/9JCvFV #socpharm #hcsm #hcmktg&lt;/span&gt;&lt;/span&gt;</description>
		<content:encoded><![CDATA[<p><span class="topsy_trackback_comment"><span class="topsy_twitter_username"><span class="topsy_trackback_content">RT @DaphneLeigh: RT @PhilBaumann: Regulatory concerns shouldn&#39;t dominate pharma online. <a href="http://bit.ly/9JCvFV" rel="nofollow">http://bit.ly/9JCvFV</a> #socpharm #hcsm #hcmktg</span></span></span></p>
]]></content:encoded>
	</item>
	<item>
		<title>By: HealthIntel</title>
		<link>http://prforpharma.com/2010/02/04/regulatory-concerns-should-not-dominate-pharma-social-media/comment-page-1/#comment-916</link>
		<dc:creator>HealthIntel</dc:creator>
		<pubDate>Sun, 07 Feb 2010 05:36:30 +0000</pubDate>
		<guid isPermaLink="false">http://prforpharma.com/?p=134#comment-916</guid>
		<description>&lt;span class=&quot;topsy_trackback_comment&quot;&gt;&lt;span class=&quot;topsy_twitter_username&quot;&gt;&lt;span class=&quot;topsy_trackback_content&quot;&gt;RT @PhilBaumann: Regulatory Concerns Shouldn&#039;t Dominate Pharma Online - http://bit.ly/9JCvFV #socpharm #hcmktg #hcsm&lt;/span&gt;&lt;/span&gt;</description>
		<content:encoded><![CDATA[<p><span class="topsy_trackback_comment"><span class="topsy_twitter_username"><span class="topsy_trackback_content">RT @PhilBaumann: Regulatory Concerns Shouldn&#39;t Dominate Pharma Online &#8211; <a href="http://bit.ly/9JCvFV" rel="nofollow">http://bit.ly/9JCvFV</a> #socpharm #hcmktg #hcsm</span></span></span></p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Daphne Swancutt</title>
		<link>http://prforpharma.com/2010/02/04/regulatory-concerns-should-not-dominate-pharma-social-media/comment-page-1/#comment-917</link>
		<dc:creator>Daphne Swancutt</dc:creator>
		<pubDate>Sun, 07 Feb 2010 05:35:50 +0000</pubDate>
		<guid isPermaLink="false">http://prforpharma.com/?p=134#comment-917</guid>
		<description>&lt;span class=&quot;topsy_trackback_comment&quot;&gt;&lt;span class=&quot;topsy_twitter_username&quot;&gt;&lt;span class=&quot;topsy_trackback_content&quot;&gt;RT @PhilBaumann: Regulatory concerns shouldn&#039;t dominate pharma online. http://bit.ly/9JCvFV #socpharm #hcsm #hcmktg&lt;/span&gt;&lt;/span&gt;</description>
		<content:encoded><![CDATA[<p><span class="topsy_trackback_comment"><span class="topsy_twitter_username"><span class="topsy_trackback_content">RT @PhilBaumann: Regulatory concerns shouldn&#39;t dominate pharma online. <a href="http://bit.ly/9JCvFV" rel="nofollow">http://bit.ly/9JCvFV</a> #socpharm #hcsm #hcmktg</span></span></span></p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Heather R. Powell</title>
		<link>http://prforpharma.com/2010/02/04/regulatory-concerns-should-not-dominate-pharma-social-media/comment-page-1/#comment-918</link>
		<dc:creator>Heather R. Powell</dc:creator>
		<pubDate>Sun, 07 Feb 2010 05:33:56 +0000</pubDate>
		<guid isPermaLink="false">http://prforpharma.com/?p=134#comment-918</guid>
		<description>&lt;span class=&quot;topsy_trackback_comment&quot;&gt;&lt;span class=&quot;topsy_twitter_username&quot;&gt;&lt;span class=&quot;topsy_trackback_content&quot;&gt;RT @PhilBaumann: Regulatory Concerns Shouldn&#039;t Dominate Pharma Online - http://bit.ly/9JCvFV #socpharm #hcmktg&lt;/span&gt;&lt;/span&gt;</description>
		<content:encoded><![CDATA[<p><span class="topsy_trackback_comment"><span class="topsy_twitter_username"><span class="topsy_trackback_content">RT @PhilBaumann: Regulatory Concerns Shouldn&#39;t Dominate Pharma Online &#8211; <a href="http://bit.ly/9JCvFV" rel="nofollow">http://bit.ly/9JCvFV</a> #socpharm #hcmktg</span></span></span></p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Phil Baumann</title>
		<link>http://prforpharma.com/2010/02/04/regulatory-concerns-should-not-dominate-pharma-social-media/comment-page-1/#comment-919</link>
		<dc:creator>Phil Baumann</dc:creator>
		<pubDate>Sun, 07 Feb 2010 05:31:31 +0000</pubDate>
		<guid isPermaLink="false">http://prforpharma.com/?p=134#comment-919</guid>
		<description>&lt;span class=&quot;topsy_trackback_comment&quot;&gt;&lt;span class=&quot;topsy_twitter_username&quot;&gt;&lt;span class=&quot;topsy_trackback_content&quot;&gt;Regulatory Concerns Shouldn&#039;t Dominate Pharma Online - http://bit.ly/9JCvFV #socpharm #hcmktg&lt;/span&gt;&lt;/span&gt;</description>
		<content:encoded><![CDATA[<p><span class="topsy_trackback_comment"><span class="topsy_twitter_username"><span class="topsy_trackback_content">Regulatory Concerns Shouldn&#39;t Dominate Pharma Online &#8211; <a href="http://bit.ly/9JCvFV" rel="nofollow">http://bit.ly/9JCvFV</a> #socpharm #hcmktg</span></span></span></p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Peter Lindroth</title>
		<link>http://prforpharma.com/2010/02/04/regulatory-concerns-should-not-dominate-pharma-social-media/comment-page-1/#comment-920</link>
		<dc:creator>Peter Lindroth</dc:creator>
		<pubDate>Sat, 06 Feb 2010 00:32:37 +0000</pubDate>
		<guid isPermaLink="false">http://prforpharma.com/?p=134#comment-920</guid>
		<description>&lt;span class=&quot;topsy_trackback_comment&quot;&gt;&lt;span class=&quot;topsy_twitter_username&quot;&gt;&lt;span class=&quot;topsy_trackback_content&quot;&gt;RT @PRforPharma: Does pharma social media focus too much on regulatory issues and not enough on the patient?: http://bit.ly/dpk6xC&lt;/span&gt;&lt;/span&gt;</description>
		<content:encoded><![CDATA[<p><span class="topsy_trackback_comment"><span class="topsy_twitter_username"><span class="topsy_trackback_content">RT @PRforPharma: Does pharma social media focus too much on regulatory issues and not enough on the patient?: <a href="http://bit.ly/dpk6xC" rel="nofollow">http://bit.ly/dpk6xC</a></span></span></span></p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Chris Iafolla</title>
		<link>http://prforpharma.com/2010/02/04/regulatory-concerns-should-not-dominate-pharma-social-media/comment-page-1/#comment-921</link>
		<dc:creator>Chris Iafolla</dc:creator>
		<pubDate>Fri, 05 Feb 2010 23:08:17 +0000</pubDate>
		<guid isPermaLink="false">http://prforpharma.com/?p=134#comment-921</guid>
		<description>&lt;span class=&quot;topsy_trackback_comment&quot;&gt;&lt;span class=&quot;topsy_twitter_username&quot;&gt;&lt;span class=&quot;topsy_trackback_content&quot;&gt;Does pharma social media focus too much on regulatory issues and not enough on the patient?: http://bit.ly/dpk6xC&lt;/span&gt;&lt;/span&gt;</description>
		<content:encoded><![CDATA[<p><span class="topsy_trackback_comment"><span class="topsy_twitter_username"><span class="topsy_trackback_content">Does pharma social media focus too much on regulatory issues and not enough on the patient?: <a href="http://bit.ly/dpk6xC" rel="nofollow">http://bit.ly/dpk6xC</a></span></span></span></p>
]]></content:encoded>
	</item>
</channel>
</rss>

